Smith Stan 4
4 · MAIA Biotechnology, Inc. · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
MAIA Biotechnology (MAIA) Director Stan Smith Buys 75,000 Shares
What Happened
Stan Smith, a director of MAIA Biotechnology, purchased 75,000 shares on June 1, 2026. The filing reports a weighted-average purchase price of $1.34 per share, for a total reported outlay of $100,200. The shares were acquired via open-market transactions (purchase code P), which investors often view as a more bullish sign than a sale, though the filing does not state Mr. Smith’s motive.
Key Details
- Transaction date: June 1, 2026; filing date: June 2, 2026 (timely).
- Reported weighted-average price: $1.34 per share; total reported value: $100,200.
- Price range and multiple trades: purchases occurred at prices from $1.32 to $1.40 (F1); reporting person can provide breakdown on request.
- Shares owned after transaction: not disclosed in this filing.
- Beneficial ownership notes: some MAIA shares are held through trusts and UTMA accounts associated with Mr. Smith (F2–F5); he disclaims beneficial ownership of the family-member accounts except to the extent of any pecuniary interest.
- Transaction code: P = Purchase (open-market/private purchase).
Context
This was a direct purchase of common stock (not an option exercise, award, or gift). Purchases by insiders can be of interest to retail investors as a signal of confidence, but filings do not explain the insider’s intent.
Insider Transaction Report
- Purchase
Common Stock
[F1][F2]2026-06-01$1.34/sh+75,000$100,200→ 1,519,178 total(indirect: See Footnote)
- 4,580(indirect: See footnote)
Common Stock
[F3] - 4,580(indirect: See footnote)
Common Stock
[F4] - 4,580(indirect: See footnote)
Common Stock
[F5]
Footnotes (5)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]These securities are beneficially owned by Mr. Smith through the Blake Sarai Teitei Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]These securities are beneficially owned by Mr. Smith through the Gage Quentin Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F5]These securities are beneficially owned by Mr. Smith through the Travis Deo Zai Zai Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.